LncRNA H19/miR-675轴靶向调控“治节重建”干预COPD肺血管重构的机制研究
批准号:
81974569
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
朱洁
依托单位:
学科分类:
中医内科学
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
朱洁
中文摘要
“肺主治节”是对肺生理功能的高度概括,其治节功能通过肺主气行使。肺气虚则治节失常,可致气虚痰凝血瘀,迁延日久导致肺系脉络失常,甚至痹阻,与现代医学COPD肺血管重构病理表现极为相似。既往研究表明,益气化痰祛瘀方药能重建肺的治节功能,改善肺血管重构。我们借助高通量测序发现,LncRNA H19/miR-675轴表达在COPD肺组织显著上调,与PASMCs异常增殖密切相关,是调控COPD肺血管重构的重要靶点,机制有待进一步探明。鉴此,项目围绕“益气化痰祛瘀方介导LncRNA H19/miR-675轴,调控治节重建,抑制PASMCs增殖,影响肺血管重构进程”的假说,拟采用体内外结合的研究方法,运用双荧光素酶报告基团检测、基因干扰和过表达等技术,以LncRNA H19/miR-675轴视角,探讨COPD肺血管干预机制,阐释益气化痰祛瘀方调控“治节重建”的科学内涵,为COPD防治提供新的证据和支持。
英文摘要
The “lung governing coordinative activities of viscera” comprehensively summarized the physiological functions of the lungs, and it is executed via lung governing qi. Lung qi deficiency results in the “lung failure coordinative activities of viscera”, which leads to the “qi deficiency, coagulation, and phlegm”, and eventually brings pulmonary dysfunction and even stagnation. This phenomenon is similar to the pathological manifestations of pulmonary vascular remodeling in COPD. It has been proved that Yiqi Huatan Quyu recipe could effectively reconstruct the pulmonary vascular and the function of the lungs. Combining with the high-throughput sequencing, we have found that the expression of LncRNA H19/miR-675 axis is significantly up-regulated in COPD lung tissue, which is closely related to the abnormal proliferation of PASMCs, and may be an important target for the regulation of COPD vascular remodeling. Nevertheless, the mechanism needs further exploration. Therefore, we hypothesize that Yiqi Huatan Quyu recipe may regulate the expression of LncRNA H19/miR-675 axis to inhibit the proliferation of PASMCs, reconstruct the function of the “lung governing coordinative activities of viscera”and further affect the process of pulmonary vascular remodeling. From the perspective of LncRNA H19/miR-675 axis, we will protocol the study of in vitro and in vivo, also combined research methods including detecting techniques like dual luciferase reporter detection, gene interference, overexpression, etc., to explore the mechanism of pulmonary vascular regulation in COPD, and explain the scientific connotation on the reconstruction of “lung governing coordinative activities of viscera” via Yiqi Huayu Recipe. We hope to provide a new evidence to support the prevention and treatment of COPD.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
--
发表时间:
2021
期刊:
安徽中医药大学学报
影响因子:
作者:
[朱张求, 石孟瑶, 方莉, 朱洁, 李泽庚, 童佳兵]
通讯作者:
童佳兵
DOI:
10.3389/fphar.2023.1258138
发表时间:
2023
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[]
通讯作者:
DOI:
--
发表时间:
2020
期刊:
细胞与分子免疫学杂志
影响因子:
作者:
[王小乐, 朱洁, 童佳兵, 吴凡, 高雅婷, 王心恒, 李泽庚]
通讯作者:
李泽庚
DOI:
10.1186/s12967-022-03481-w
发表时间:
2022-06-21
期刊:
JOURNAL OF TRANSLATIONAL MEDICINE
影响因子:
7.4
作者:
[Jia, Yu, He, Tiantian, Wu, Di, Tong, Jiabing, Zhu, Jie, Li, Zegeng, Dong, Jingcheng]
通讯作者:
Dong, Jingcheng
DOI:
10.3389/fphar.2022.978151
发表时间:
2022
期刊:
Frontiers in pharmacology
影响因子:
5.6
作者:
[]
通讯作者:
共 7 条
基于Ca2+-Calcineurin-NFAT信号通路的益气化痰祛瘀方对COPD肺血管重构的机制研究
-
批准号:81403308
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2014
-
负责人:朱洁
-
依托单位:
国内基金
海外基金